BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Treatment
134 results:

  • 1. The Janus face of mitophagy in myocardial ischemia/reperfusion injury and recovery.
    Deng J; Liu Q; Ye L; Wang S; Song Z; Zhu M; Qiang F; Zhou Y; Guo Z; Zhang W; Chen T
    Biomed Pharmacother; 2024 Apr; 173():116337. PubMed ID: 38422659
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. N-Acetylcysteine Alters Disease Progression and Increases Janus Kinase Mutation Frequency in a Mouse Model of Precursor B-Cell Acute Lymphoblastic Leukemia.
    Sams MP; Iansavitchous J; Astridge M; Rysan H; Xu LS; Rodrigues de Oliveira B; DeKoter RP
    J Pharmacol Exp Ther; 2024 Mar; 389(1):40-50. PubMed ID: 38336380
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The gene expression profile and cell of origin of canine peripheral T-cell lymphoma.
    Owens E; Harris L; Harris A; Yoshimoto J; Burnett R; Avery A
    BMC Cancer; 2024 Jan; 24(1):18. PubMed ID: 38166662
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Inhibition of PRL2 Upregulates pten and Attenuates Tumor Growth in Tp53-deficient Sarcoma and lymphoma Mouse Models.
    Nguele Meke F; Bai Y; Ruiz-Avila D; Carlock C; Ayub J; Miao J; Hu Y; Li Q; Zhang ZY
    Cancer Res Commun; 2024 Jan; 4(1):5-17. PubMed ID: 38047587
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Baseline tumor gene expression signatures correlate with chemoimmunotherapy treatment responsiveness in canine B cell lymphoma.
    Dittrich K; Yıldız-Altay Ü; Qutab F; Kwong DA; Rao Z; Nievez-Lozano SA; Gardner HL; Richmond JM; London CA
    PLoS One; 2023; 18(8):e0290428. PubMed ID: 37624862
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. BRAF(V600E) mutation together with loss of Trp53 or pten drives the origination of hairy cell leukemia from B-lymphocytes.
    Yap J; Yuan J; Ng WH; Chen GB; Sim YRM; Goh KC; Teo J; Lim TYH; Goay SM; Teo JHJ; Lao Z; Lam P; Sabapathy K; Hu J
    Mol Cancer; 2023 Aug; 22(1):125. PubMed ID: 37543582
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Characteristics of Molecular Genetic Mutations and Their Correlation with Prognosis in Adolescent and Adult Patients with Acute Lymphoblastic Leukemia.
    Sun X; Liu X; Li Y; Shi X; Li Y; Tan R; Jiang Y; Sui X; Ge X; Xu H; Wang X; Fang X
    Oncology; 2024; 102(1):85-98. PubMed ID: 37437551
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Spectrum and clinical features of gene mutations in Chinese pediatric acute lymphoblastic leukemia.
    Shen D; Liu L; Xu X; Song H; Zhang J; Xu W; Zhao F; Liang J; Liao C; Wang Y; Xia T; Wang C; Lou F; Cao S; Qin J; Tang Y
    BMC Pediatr; 2023 Feb; 23(1):62. PubMed ID: 36739388
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The evaluation of gene mutation profiles by next-generation sequencing in diffuse large B-cell lymphoma.
    Özçalımlı A; Erdoğdu İH; Turgutkaya A; Yavaşoğlu İ; Döger FK; Bolaman AZ
    Int J Lab Hematol; 2023 Jun; 45(3):310-316. PubMed ID: 36576110
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Gastric SWI/SNF complex deletion-associated undifferentiated carcinoma with rhabdoid phenotype: a clinicopathological and molecular analysis].
    Jin YP; Wang L; Wang Y; Wu DY; Zhang H; Xia QX
    Zhonghua Bing Li Xue Za Zhi; 2022 Dec; 51(12):1229-1234. PubMed ID: 36480831
    [No Abstract]    [Full Text] [Related]  

  • 11. mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma.
    Xu W; Berning P; Erdmann T; Grau M; Bettazová N; Zapukhlyak M; Frontzek F; Kosnopfel C; Lenz P; Grondine M; Willis B; Lynch JT; Klener P; Hailfinger S; Barry ST; Lenz G
    Leukemia; 2023 Jan; 37(1):178-189. PubMed ID: 36352190
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Inhibition of acylglycerol kinase sensitizes DLBCL to venetoclax via upregulation of FOXO1-mediated BCL-2 expression.
    Ning N; Zhang S; Wu Q; Li X; Kuang D; Duan Y; Xia M; Liu H; Weng J; Ba H; Tang Z; Cheng X; Mei H; Huang L; Ao Q; Wang G; Hu Y; Laurence A; Wang J; Wang G; Yang XP
    Theranostics; 2022; 12(12):5537-5550. PubMed ID: 35910796
    [No Abstract]    [Full Text] [Related]  

  • 13. The oncoprotein BCL6 enables solid tumor cells to evade genotoxic stress.
    Liu Y; Feng J; Yuan K; Wu Z; Hu L; Lu Y; Li K; Guo J; Chen J; Ma C; Pang X
    Elife; 2022 May; 11():. PubMed ID: 35503721
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Apoptotic and DNA Damage Effect of 1,2,3,4,6-Penta-O-galloyl-beta-D-glucose in Cisplatin-Resistant Non-Small Lung Cancer Cells via Phosphorylation of H
    Kim JH; Im E; Lee J; Lee HJ; Sim DY; Park JE; Ahn CH; Kwon HH; Shim BS; Kim B; Kim SH
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456022
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Optimized outcome prediction of oncogenetic mutations in non-early T-cell precursor acute lymphoblastic leukemia.
    Peng LJ; Wang SS; Guo SS; Zhang JJ; Liu YF; Rousseaux S; Khochbin S; Chen B; Wang J; Mi JQ
    Immunobiology; 2022 May; 227(3):152205. PubMed ID: 35279479
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. pten/PI3K/Akt pathway alters sensitivity of T-cell acute lymphoblastic leukemia to L-asparaginase.
    Hlozkova K; Hermanova I; Safrhansova L; Alquezar-Artieda N; Kuzilkova D; Vavrova A; Sperkova K; Zaliova M; Stary J; Trka J; Starkova J
    Sci Rep; 2022 Mar; 12(1):4043. PubMed ID: 35260738
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Roles of BMI1 in the Initiation, Progression, and treatment of Hepatocellular Carcinoma.
    Wang R; Fan H; Sun M; Lv Z; Yi W
    Technol Cancer Res Treat; 2022; 21():15330338211070689. PubMed ID: 35072573
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Cooperative miRNA-dependent pten regulation drives resistance to BTK inhibition in B-cell lymphoid malignancies.
    Kapoor I; Bodo J; Hill BT; Almasan A
    Cell Death Dis; 2021 Nov; 12(11):1061. PubMed ID: 34750354
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical benefits of precision medicine in treating solid cancers: European Society of Medical Oncology-Magnitude of Clinical Benefit Scale score-based analysis.
    Hibino Y; Ito M; Satake T; Kondo S
    ESMO Open; 2021 Aug; 6(4):100187. PubMed ID: 34118770
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. microRNA-181a promotes the proliferation of hypertrophic scar fibroblasts and inhibits their apoptosis via targeting phosphatase and tensin homolog.
    Zhou Y; Shi X; Li S; Gan Q; Cui Z
    Ann Palliat Med; 2021 Apr; 10(4):4563-4571. PubMed ID: 33966404
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.